367 related articles for article (PubMed ID: 25477193)
1. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
Calebiro D; Bathon K; Weigand I
Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
[TBL] [Abstract][Full Text] [Related]
3. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
[TBL] [Abstract][Full Text] [Related]
4. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
[TBL] [Abstract][Full Text] [Related]
5. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
[TBL] [Abstract][Full Text] [Related]
6. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
8. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
[TBL] [Abstract][Full Text] [Related]
9. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
[TBL] [Abstract][Full Text] [Related]
10. The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.
Blumenthal DK; Copps J; Smith-Nguyen EV; Zhang P; Heller WT; Taylor SS
J Biol Chem; 2014 Oct; 289(41):28505-12. PubMed ID: 25112875
[TBL] [Abstract][Full Text] [Related]
11. Mapping the Free Energy Landscape of PKA Inhibition and Activation: A Double-Conformational Selection Model for the Tandem cAMP-Binding Domains of PKA RIα.
Akimoto M; McNicholl ET; Ramkissoon A; Moleschi K; Taylor SS; Melacini G
PLoS Biol; 2015; 13(11):e1002305. PubMed ID: 26618408
[TBL] [Abstract][Full Text] [Related]
12. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cAMP-dependent protein kinases: the human protein kinase X (PrKX) reveals the role of the catalytic subunit alphaH-alphaI loop.
Diskar M; Zenn HM; Kaupisch A; Kaufholz M; Brockmeyer S; Sohmen D; Berrera M; Zaccolo M; Boshart M; Herberg FW; Prinz A
J Biol Chem; 2010 Nov; 285(46):35910-8. PubMed ID: 20819953
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
[TBL] [Abstract][Full Text] [Related]
16. Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.
Lu TW; Wu J; Aoto PC; Weng JH; Ahuja LG; Sun N; Cheng CY; Zhang P; Taylor SS
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16347-16356. PubMed ID: 31363049
[TBL] [Abstract][Full Text] [Related]
17. Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Hum Mol Genet; 2018 Aug; 27(15):2604-2613. PubMed ID: 29726992
[TBL] [Abstract][Full Text] [Related]
18. Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?
Walker C; Wang Y; Olivieri C; V S M; Gao J; Bernlohr DA; Calebiro D; Taylor SS; Veglia G
J Mol Biol; 2021 Sep; 433(18):167123. PubMed ID: 34224748
[TBL] [Abstract][Full Text] [Related]
19. Structural analyses of the PKA RIIβ holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma.
Lu TW; Aoto PC; Weng JH; Nielsen C; Cash JN; Hall J; Zhang P; Simon SM; Cianfrocco MA; Taylor SS
PLoS Biol; 2020 Dec; 18(12):e3001018. PubMed ID: 33370777
[TBL] [Abstract][Full Text] [Related]
20. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
